- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 239/24 - Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
Patent holdings for IPC class C07D 239/24
Total number of patents in this class: 144
10-year publication summary
|
17
|
5
|
15
|
10
|
11
|
15
|
4
|
5
|
10
|
4
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| LG Chem, Ltd. | 17561 |
7 |
| Arvinas Operations, Inc. | 225 |
7 |
| Samsung Display Co., Ltd. | 34230 |
4 |
| Hutchison MediPharma Limited | 103 |
4 |
| Beyondbio Inc. | 9 |
4 |
| Merck Sharp & Dohme LLC | 3741 |
4 |
| Boehringer Ingelheim International GmbH | 4704 |
3 |
| Calitor Sciences, LLC | 37 |
3 |
| Dana-Farber Cancer Institute, Inc. | 2553 |
3 |
| Medshine Discovery Inc. | 606 |
3 |
| Sunshine Lake Pharma Co., Ltd. | 588 |
3 |
| Merck Sharp & Dohme Corp. | 2201 |
2 |
| AstraZeneca AB | 2928 |
2 |
| Semiconductor Energy Laboratory Co., Ltd. | 11358 |
2 |
| University of Florida Research Foundation, Inc. | 3989 |
2 |
| 10X Genomics, Inc. | 1184 |
2 |
| Curtana Pharmaceuticals, Inc. | 13 |
2 |
| Gracel Display Inc. | 23 |
2 |
| Institute of Pharmacology and Toxicology Academy of Military Medical Sciences P.L.A. China | 186 |
2 |
| National Health Research Institutes | 324 |
2 |
| Other owners | 81 |